MOTTA, IRENE
MOTTA, IRENE
Dipartimento di Scienze Cliniche e di Comunità
Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease
2024 F. Casarin, R. Mascolo, I. Motta, M.A. Wu, E. Bizzi, A. Pedroli, G. Dieguez, G. Iacomelli, L. Serati, L. Duca, S. Maestroni, E. Tombetti, M.D. Cappellini, A. Brucato
Step out of the shadows: a call for action for rare diseases
2024 F. Granata, R. Bou Fakhredin, M.D. Cappellini, I. Motta
Deciphering cytopenias in internal medicine: a single-center observational study
2024 S. Leoni, M. Ferraresi, I. Motta, C. Hu, A.L. Fracanzani, W. Barcellini, B. Fattizzo
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
2024 S. Leoni, R. Bou Fakhredin, F. Granata, E. Cassinerio, M. Maggioni, A.L. Fracanzani, M.D. Cappellini, I. Motta
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia
2024 D.L. Panzieri, D. Consonni, N. Scaramellini, G. Ausenda, F. Granata, N. Caponio, L. Duca, S. Leoni, S. Elli, M. Ferraresi, V. Bolis, C. Curcio, M.A. Irrera, D. Maira, G. Graziadei, E. Cassinerio, M.D. Cappellini, R. Bou-Fakhredin, V. Brancaleoni, I. Motta
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease
2024 I. Motta, P. Delbini, N. Scaramellini, V. Ghiandai, L. Duca, I. Nava, F. Nascimbeni, S. Lugari, D. Consonni, E. Trombetta, V. Di Stefano, M. Migone De Amicis, E. Cassinerio, F. Carubbi, M.D. Cappellini
A glutamine metabolic switch supports erythropoiesis
2024 J. Lyu, Z. Gu, Y. Zhang, H.S. Vu, C. Lechauve, F. Cai, H. Cao, J. Keith, V. Brancaleoni, F. Granata, I. Motta, M.D. Cappellini, L.J. Huang, R.J. Deberardinis, M.J. Weiss, M. Ni, J. Xu
Clinical complications and their management
2023 R. Bou-Fakhredin, I. Motta, M.D. Cappellini, A.T. Taher
Interpreting Iron Homeostasis in Congenital and Acquired Disorders
2023 N. Scaramellini, D. Fischer, A.R. Agarvas, I. Motta, M.U. Muckenthaler, C. Mertens
Rise of the planet of rare anemias: An update on emerging treatment strategies
2023 B. Fattizzo, I. Motta
Iron status in chronic inflammatory disease: therapeutic implications
2023 M.D. Cappellini, N. Scaramellini, I. Motta
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis
2023 M.D. Cappellini, I. Motta, A. Barbato, G. Giuffrida, R. Manna, F. Carubbi, F. Giona
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence
2023 F. Longo, I. Motta, V. Maria Pinto, A. Piolatto, P. Ricchi, I. Tartaglione, R. Origa
Anemia management and transfusion strategy in internal medicine units: Less is more
2023 D. Blanca, G. Parrella, D. Consonni, S. Villa, G. Ceriani, A. Cespiati, G. Figini, G. Ghigliazza, D. Maira, G. Oberti, N. Scaramellini, G.L. Schinco, F. Tafuri, N. Montano, M.D. Cappellini, I. Motta
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease
2023 M. Ferraresi, D.L. Panzieri, S. Leoni, M.D. Cappellini, A. Kattamis, I. Motta
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia
2023 A. Aprile, L. Raggi, S. Bolamperti, I. Villa, M. Storto, G. Morello, S. Marktel, C. Tripodo, M.D. Cappellini, I. Motta, A. Rubinacci, G. Ferrari
Drug design and development for rare hematologic diseases
2023 B. Fattizzo, M. Capecchi, I. Motta
Effect of Migalastat on cArdiac InvOlvement in FabRry DiseAse: MAIORA study
2023 A. Camporeale, F. Bandera, M. Pieroni, F. Pieruzzi, M. Spada, A. Bersano, L. Econimo, C. Lanzillo, M. Rubino, R. Mignani, I. Motta, I. Olivotto, I. Tanini, R. Valaperta, K. Chow, I. Baroni, S. Boveri, F. Graziani, S. Pica, L. Tondi, M. Guazzi, M. Lombardi
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
2022 I. El-Battrawy, F. Longo, I.J. Nunez Gil, M. Abumayyaleh, B. Gianesin, V. Estrada, A. Aparisi, R. Arroyo-Espliguero, M. Balocco, S. Barella, A. Beccaria, F. Bonetti, M. Casale, E. De michele, A.R. Denotti, C. Fidone, M. Fortini, M.R. Gamberini, G. Graziadei, R. Lisi, A. Massa, A. Marcon, B. Rubinski, M. Miano, I. Motta, V.M. Pinto, A. Piperno, R. Mariani, M.C. Putti, A. Quota, M. Ribersani, M. Marziali, D. Roberti, R. Rosso, I. Tartaglione, A. Vitucci, V. Voi, M. Zecca, R. Romero, C. Marouneld, I. Fernandez-Rozas, C. Espejo, W. Marhaeni, M. Garcia Aguado, M.D. Cappellini, S. Perrotta, L. De Franceschi, A. Piga, G.L. Forni, I. Akin
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
2022 A.T. Taher, M.D. Cappellini, A. Kattamis, E. Voskaridou, S. Perrotta, A.G. Piga, A. Filosa, J.B. Porter, T.D. Coates, G.L. Forni, A.A. Thompson, I. Tartaglione, K.M. Musallam, J.T. Backstrom, O. Esposito, A.C. Giuseppi, W.L. Kuo, D. Miteva, J. Lord-Bessen, A. Yucel, T. Zinger, J.K. Shetty, V. Viprakasit, J. Buaboonnam, S. Ekwattanakit, A. Khunhapinant, E. Loka, M. Moraki, P. Flevari, M. Dimopoulou, V. Bartzi, H. Daadaa, G. El Hasbani, S. Koussa, F. Ammendola, S. Scianguetta, M. Puglia, I. Ferrara, G. Ferrero, C. Gaglioti, F. Longo, S. Turrini, V. Voi, E. Cassinerio, A. De, G. Graziadei, A. Marcon, M. Migone De Amicis, I. Motta, P. Cinque, B. Pannone, P. Ricchi, M. Balocco, P. Carrara, F. Della Rovere, M. Lamagna, V. Pinto, S. Quintino, P. Eleftheriou, M. Garbowski, A. de Kreuk, S. Carson, C. Denton, T. Hofstra, S. Veluswamy, J. Wood, S. Badawy, R. Bercovitz, R. Bhat, D. Calamaras, R. Liem, A. Mack